Pendal Group LTD Guardant Health, Inc. Transaction History

Pendal Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$28.82 - $77.35 $99,947 - $268,249	-3,468 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$98.77 - $132.17 $4,938 - $6,608	50 Added 1.46%	3,468 $434,000
Q2 2021 Jul 28, 2021	SELL	$109.77 - $165.68 $7,903 - $11,928	-72 Reduced 2.06%	3,418 $424,000
Q1 2021 May 24, 2021	BUY	$127.04 - $179.1 $443,369 - $625,059	3,490 New	3,490 $533,000
Q1 2021 May 03, 2021	SELL	$127.04 - $179.1 $643,457 - $907,141	-5,065 Closed	0 $0

Q3 2020 Nov 02, 2020	BUY	$80.32 - $111.8 $16,063 - $22,360	200 Added 4.11%	5,065 $566,000
Q2 2020 Aug 07, 2020	BUY	$60.49 - $97.5 $168,706 - $271,927	2,789 Added 134.34%	4,865 $395,000
Q1 2020 May 04, 2020	SELL	$59.04 - $88.81 $228,484 - $343,694	-3,870 Reduced 65.09%	2,076 $144,000
Q4 2019 Feb 06, 2020	BUY	$59.49 - $82.78 $65,498 - $91,140	1,101 Added 22.72%	5,946 $464,000
Q2 2019 Aug 01, 2019	BUY	$63.94 - $91.11 $24,936 - $35,532	390 Added 8.75%	4,845 $0
Q1 2019 May 01, 2019	SELL	$34.3 - $97.98 $41,503 - $118,555	-1,210 Reduced 21.36%	4,455 $0
Q4 2018 Jan 30, 2019	BUY	$29.2 - $46.1 $165,418 - $261,156	5,665 New	5,665 $212,000

309

110M

2.51M

1.7M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.95B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.